Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms

Bone Marrow Transplantation volume 44, pages 7–12 (2009)Cite this article

Abstract

Allogeneic haematopoietic cell transplantation is an established curative treatment modality for patients with malignant and non-malignant haematological disorders. Since the first related umbilical cord blood transplant (UCBT) in 1988, the use of UCB as a stem cell source for transplantation has become a standard practice in many countries, with approximately 8000 such transplants having been performed worldwide to date.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.

    Article  CAS  Google Scholar 

  2. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.

    Article  Google Scholar 

  3. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  Google Scholar 

  4. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.

    Article  CAS  Google Scholar 

  5. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  Google Scholar 

  6. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947–1954.

    Article  Google Scholar 

  7. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  Google Scholar 

  8. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  9. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275.

    Article  CAS  Google Scholar 

  10. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276–2285.

    Article  CAS  Google Scholar 

  11. de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 2008; 41: 771–778.

    Article  CAS  Google Scholar 

  12. Fernandez MN, Regidor C, Cabrera R, Garcia-Marco JA, Fores R, Sanjuan I et al. Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535–544.

    Article  Google Scholar 

  13. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343–1347.

    Article  CAS  Google Scholar 

  14. Sanz J, Arcese W, Hernandez-Boluda JC, Ferra C, Gonzalez M, Martin C et al. Low transplant-related mortality in patients with hematologic malignancies undergoing umbilical cord Blood Transplantation (UCBT) with Thiotepa (TT), Once-Daily Intravenous (IV) Busulfan (BU), Fludarabine (FLU) and Anti-Thymocyte Globulin (ATG). ASH Annual Meeting Abstracts 2007; 110: 618.

    Google Scholar 

  15. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064–3070.

    Article  CAS  Google Scholar 

  16. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007; 13: 82–89.

    Article  CAS  Google Scholar 

  17. Komatsu T, Narimatsu H, Yoshimi A, Kurita N, Kusakabe M, Hori A et al. Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol 2007; 86: 49–54.

    Article  CAS  Google Scholar 

  18. Misawa M, Kai S, Okada M, Nakajima T, Nomura K, Wakae T et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 2006; 83: 74–79.

    Article  CAS  Google Scholar 

  19. Yuji K, Miyakoshi S, Kato D, Miura Y, Myojo T, Murashige N et al. Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma. Biol Blood Marrow Transplant 2005; 11: 314–318.

    Article  Google Scholar 

  20. Rocha V, Rio B, Garnier F, Renaud M, Sirvent A, Takahashi S et al. Reduced intensity conditioning regimen in single unrelated cord blood transplantation in adults with hematological malignant disorders. An Eurocord-Netcord and SFGM-TC Survey. ASH Annual Meeting Abstracts 2006; 108: 3143.

    Google Scholar 

  21. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein–Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.

    Article  CAS  Google Scholar 

  22. Goldman JM, Schmitz N, Niethammer D, Gratwohl A . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 1–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Haemato-Oncology, Royal Marsden Hospital, Surrey, UK

    B E Shaw & M N Potter

  2. Research Department, Anthony Nolan Trust, London, UK

    B E Shaw, J Addada, J Goldman, J A Madrigal & S Querol

  3. Department of Haematology, Great Ormond Street Hospital, London, UK

    P Veys

  4. Department of Haematology, King's College Hospital, London, UK

    A Pagliuca & S Querol

  5. Department of Haematology, Blood and Marrow Transplant Centre, St James' University Hospital, Leeds, UK

    G Cook

  6. Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK

    C F Craddock

  7. Department of Paediatric Immunology and BMT, Newcastle University, Newcastle, UK

    A R Gennery

  8. Department of Medicine, Royal Free and University College London School of Medicine, London, UK

    S Mackinnon & J A Madrigal

  9. Department of Haematology, Bristol Childrens Hospital, Bristol, UK

    D I Marks

  10. NHS Blood and Transplant, London, UK

    C Navarrete & F Regan

  11. Division of Infection and Immunity, University College of London, London, UK

    C Navarrete

  12. Department of Haematology, Nottingham University Hospitals (City Campus), Nottingham, UK

    N H Russell

  13. Children and Young People's Cancer Service, UCLH, London, UK

    R E Hough

Authors
  1. B E Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Veys
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Pagliuca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Addada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Cook
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C F Craddock
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A R Gennery
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Mackinnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J A Madrigal
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D I Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M N Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. S Querol
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. F Regan
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. N H Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. R E Hough
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B E Shaw.

Appendix 1

Appendix 1

Attendees at the meeting

Persis Amrolia (London); Juliet Barker (New York); Andy Clark (Glasgow); Marcela Contreras (London); Nichola Cooper (London); Jackie Cornish (Bristol); Charlie Craddock (Birmingham); Andy Gennery (Newcastle); John Girdlestone (London); John Goldman (London); Nick Goulden (London); Rajeev Gupta (Oxford); Rachael Hough (London); Michael LeBrocq (London); David Linch (London); Steve Mackinnon (London); Alejandro Madrigal (London); Emma Morris (London); Cristina Navarrete (London); Eduardo Olavarria (London); Tony Pagliuca (London); Karl Peggs (London); Andy Peniket (Oxford); Mike Potter (London); Sergio Querol (London); Fiona Regan (London); Nigel Russell (Nottingham); Lionel Salama (London); Bronwen Shaw (London); Jon Smythe (Oxford); Phyllis Teasdale (London); Paul Veys (London).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shaw, B., Veys, P., Pagliuca, A. et al. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant 44, 7–12 (2009). https://doi.org/10.1038/bmt.2008.420

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.420

Keywords

This article is cited by

Search

Advanced search

Quick links